Our current product provides modality selection support for patients with end stage renal disease.

Ayogo allows Drug and Device companies to ensure high rates of activation, adherence and persistence, by identifying the causes of a patient’s poor engagement and tailoring content, tools, and support to directly address them.

Ayogo is a Platform as a Service that enables Drug and Device companies to deliver higher value in their patient success programs.

Our platform aggregates data from a variety of sources to build a psychometric profile of a patient, and enables individualized tailoring of digital content, tools, and support. It helps patients making transitions in care avoid expensive treatment failures. Our beachhead market is end-stage renal disease....
Our current product provides modality selection support for patients with end stage renal disease.

Ayogo allows Drug and Device companies to ensure high rates of activation, adherence and persistence, by identifying the causes of a patient’s poor engagement and tailoring content, tools, and support to directly address them.

Ayogo is a Platform as a Service that enables Drug and Device companies to deliver higher value in their patient success programs.

Our platform aggregates data from a variety of sources to build a psychometric profile of a patient, and enables individualized tailoring of digital content, tools, and support. It helps patients making transitions in care avoid expensive treatment failures. Our beachhead market is end-stage renal disease.
More information
+2

Employees